News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
240,071 Results
Type
Article (7561)
Company Profile (31)
Press Release (232475)
Multimedia
Podcasts (14)
Webinars (9)
Section
Business (74315)
Career Advice (301)
Deals (11760)
Drug Delivery (54)
Drug Development (19951)
Employer Resources (44)
FDA (6423)
Job Trends (6064)
News (113012)
Policy (10273)
Tag
2027 Genetown Elite (1)
Academia (835)
Accelerated approval (16)
Adcomms (4)
Allergies (61)
Alliances (17617)
ALS (60)
Alzheimer's disease (709)
Antibody-drug conjugate (ADC) (102)
Approvals (6739)
Artificial intelligence (281)
Autoimmune disease (44)
Automation (17)
Bankruptcy (82)
Best Places to Work (5778)
BIOSECURE Act (10)
Biosimilars (156)
Biotechnology (17)
Bladder cancer (82)
Brain cancer (24)
Breast cancer (250)
Cancer (1957)
Cardiovascular disease (189)
Career advice (267)
Career pathing (8)
CAR-T (127)
CDC (11)
Celiac Disease (1)
Cell therapy (348)
Cervical cancer (16)
Clinical research (17984)
Collaboration (917)
Compensation (65)
Complete response letters (16)
COVID-19 (870)
CRISPR (43)
C-suite (246)
Cystic fibrosis (27)
Data (2550)
Decentralized trials (2)
Denatured (7)
Depression (63)
Diabetes (229)
Diagnostics (3107)
Digital health (28)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (95)
Drug pricing (107)
Drug shortages (9)
Duchenne muscular dystrophy (89)
Earnings (45928)
Editorial (17)
Employer branding (8)
Employer resources (43)
Events (46905)
Executive appointments (292)
FDA (8155)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (554)
Gene editing (82)
Generative AI (19)
Gene therapy (238)
GLP-1 (325)
Government (1859)
Grass and pollen (4)
Guidances (300)
Healthcare (8693)
HIV (32)
Huntington's disease (9)
IgA nephropathy (35)
Immunology and inflammation (65)
Immuno-oncology (21)
Indications (55)
Infectious disease (998)
Inflammatory bowel disease (60)
Inflation Reduction Act (10)
Influenza (53)
Intellectual property (82)
Interviews (38)
IPO (6245)
IRA (24)
Job creations (594)
Job search strategy (230)
JPM (14)
Kidney cancer (7)
Labor market (13)
Layoffs (61)
Leadership (5)
Legal (1581)
Liver cancer (35)
Longevity (9)
Lung cancer (233)
Lymphoma (194)
Machine learning (23)
Management (11)
Manufacturing (377)
MASH (63)
Medical device (7065)
Medtech (7094)
Mergers & acquisitions (5967)
Metabolic disorders (517)
Multiple sclerosis (84)
NASH (5)
Neurodegenerative disease (129)
Neuropsychiatric disorders (26)
Neuroscience (1168)
NextGen: Class of 2026 (2357)
Non-profit (2293)
Now hiring (4)
Obesity (213)
Opinion (90)
Ovarian cancer (49)
Pain (87)
Pancreatic cancer (76)
Parkinson's disease (86)
Partnered (19)
Patents (145)
Patient recruitment (178)
Peanut (16)
People (11469)
Pharmaceutical (11)
Pharmacy benefit managers (21)
Phase 1 (4740)
Phase 2 (7351)
Phase 3 (7315)
Pipeline (2712)
Policy (126)
Postmarket research (679)
Preclinical (1743)
Press Release (21)
Prostate cancer (105)
Psychedelics (8)
Radiopharmaceuticals (100)
Rare diseases (341)
Real estate (1655)
Recruiting (19)
Regulatory (8862)
Reports (17)
Research institute (885)
Resumes & cover letters (42)
Rett syndrome (16)
RNA editing (4)
RSV (32)
Schizophrenia (51)
Series A (85)
Series B (56)
Service/supplier (2)
Sickle cell disease (60)
Special edition (3)
Spinal muscular atrophy (54)
Sponsored (14)
Startups (892)
Stomach cancer (4)
Supply chain (56)
Tariffs (26)
The Weekly (6)
Vaccines (337)
Venture capital (18)
Weight loss (131)
Women's health (61)
Worklife (3)
Date
Last 7 days (306)
Last 30 days (978)
Last 365 days (14041)
2026 (1287)
2025 (14318)
2024 (15668)
2023 (17580)
2022 (22054)
2021 (23348)
2020 (22426)
2019 (18565)
2018 (13438)
2017 (10301)
2016 (9685)
2015 (11452)
2014 (7975)
2013 (6043)
2012 (6543)
2011 (6778)
2010 (5854)
Location
Africa (246)
Alabama (41)
Alaska (4)
Arizona (115)
Arkansas (10)
Asia (11893)
Australia (1627)
California (5000)
Canada (1429)
China (403)
Colorado (264)
Connecticut (260)
Delaware (174)
Europe (30143)
Florida (891)
Georgia (203)
Hawaii (1)
Idaho (22)
Illinois (474)
India (37)
Indiana (344)
Iowa (3)
Japan (176)
Kansas (42)
Kentucky (16)
Louisiana (18)
Maine (61)
Maryland (632)
Massachusetts (3199)
Michigan (142)
Minnesota (389)
Mississippi (2)
Missouri (82)
Montana (15)
Nebraska (9)
Nevada (50)
New Hampshire (53)
New Jersey (1469)
New Mexico (18)
New York (1442)
North Carolina (735)
North Dakota (3)
Northern California (2449)
Ohio (160)
Oklahoma (12)
Oregon (16)
Pennsylvania (968)
Puerto Rico (19)
Rhode Island (21)
South America (319)
South Carolina (29)
South Dakota (1)
Southern California (1922)
Tennessee (111)
Texas (650)
United States (18359)
Utah (149)
Virginia (100)
Washington D.C. (38)
Washington State (437)
West Virginia (2)
Wisconsin (60)
Wyoming (2)
240,071 Results for "access vascular".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vexev’s VxWave System Successfully Meets Clinical Endpoints in Landmark Study Evaluating Robotic Ultrasound Scanning for Mapping Vascular Access at U.S. Renal Care Dialysis Clinics
November 11, 2025
·
4 min read
Press Releases
CORRECTING and REPLACING Access Vascular Highlights New Midline Catheter Data at AVA 2024
Data Presented at the AVA Annual Scientific Meeting Shows Significantly Lower Complication and Failure Rates with Access Vascular’s HydroMID® Midline Catheter
October 2, 2024
·
2 min read
Press Releases
Hemostemix Presents ACP-01 Data at University of Florida Grand Rounds: Highlights Strong Safety, Functional Gains, and Florida Access Pathway
Session led by neurosurgeon Dr. Fraser Henderson and Hemostemix CEO Thomas Smeenk for the University of Florida’s Department of Surgery, Division of Vascular Surgery & Endovascular Therapy (Gainesville)
November 13, 2025
·
10 min read
Press Releases
Covalon Announces Exciting New Clinical Research Evaluating VALGuard® Vascular Access Line Guard
May 27, 2025
·
4 min read
Press Releases
Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances
February 3, 2026
·
7 min read
Genetown
Access Vascular Announces New Bacterial Adhesion Data at INS 2024
Access Vascular, Inc. announced findings from new data showing a reduction in bacterial adhesion and thrombus accumulation in peripherally inserted central catheters and midline catheters with AVI’s MIMIX® hydrophilic biomaterial compared with conventional catheters.
May 21, 2024
·
4 min read
Press Releases
Results from Humacyte’s V007 Pivotal Phase 3 AV Access Study Highlighted by Presentation at the Society for Vascular Surgery Meeting
June 9, 2025
·
7 min read
Press Releases
Hemostemix Appoints Renowned Vascular Surgeon and Principal Investigator, Dr. York Hsiang, as Business Consultant to Advance First Nations-Led Healthcare Partnerships
February 3, 2026
·
1 min read
Genetown
Access Vascular Supports Updated Standards of Care Emphasizing New Materials to Reduce Catheter Complications
Access Vascular, Inc. announced that the Infusion Nurses Society has updated its standard of care to include innovative catheter materials, to reduce the risk of vascular access complications.
February 28, 2024
·
3 min read
Press Releases
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership
February 2, 2026
·
8 min read
1 of 24,008
Next
